Seminars in Nephrology
Volume 28, Issue 4 , Pages 409-415 , July 2008

Viral Hemorrhagic Fever–Induced Acute Kidney Injury

  • Emerson Q. Lima, MD, PhD

      Affiliations

    • Division of Nephrology, Sao Jose do Rio Preto Medical School, Sao Jose do Rio Preto, Sao Paulo, Brazil.
    • Corresponding Author InformationAddress reprint requests to Emerson Q. Lima, MD, PhD, Av. Brigadeiro Faria Lima 5416, São Jose do Rio Preto, Sao Paulo, Brazil 15090-000.
    • ,
  • Mauricio L. Nogueira, MD, PhD

      Affiliations

    • Laboratory of Virology, Division of Infectious Diseases, Sao Jose do Rio Preto Medical School, Sao Jose do Rio Preto, Sao Paulo, Brazil.

References 

  1. Futrakul P, Poshyachinda V, Mitrakul C, Kun-Anake C, Boonpucknavig V, Boonpucknavig V, et al. Renal involvement and reticulo-endothelial-system clearance in dengue hemorrhagic fever. J Med Assoc Thai. 1973;56:33–39
  2. Boonpucknavig V, Bhamarapravati N, Boonpucknavig S, Futrakul P, Tanpaichitr P. Glomerular changes in dengue hemorrhagic fever. Arch Pathol Lab Med. 1976;100:206–212
  3. George R, Liam CK, Chua CT, Lam SK, Pang T, Geethan R, et al. Unusual clinical manifestations of dengue virus infection. Southeast Asian J Trop Med Public Health. 1988;19:585–590
  4. Hommel D, Talarmin A, Reynes JM, Hulin A. Acute renal failure associated with dengue fever in French Guiana. Nephron. 1999;83:183
  5. Gunasekera HH, Adikaram AV, Herath CA, Samarasinghe HH. Myoglobinuric acute renal failure following dengue viral infection. Ceylon Med J. 2000;45:181
  6. Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanik K, Yogsan S, et al. Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai. 2002;85(Suppl 2):S522–S529
  7. Radakovic-Fijan S, Graninger W, Muller C, Honigsmann H, Tanew A. Dengue hemorrhagic fever in a British travel guide. J Am Acad Dermatol. 2002;46:430–433
  8. Mendez A, Gonzalez G. Dengue haemorrhagic fever in children: ten years of clinical experience. Biomedica. 2003;23:180–193
  9. Chacko B, John GT, Jacob CK, Vijayakumar TS. Dengue shock syndrome in a renal transplant recipient. Transplantation. 2004;77:634–635
  10. Davis JS, Bourke P. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis. 2004;38:e109–e111
  11. Lee IK, Liu JW, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:221–226
  12. Abboud O. Tropical acute renal failure (Third Congress of Nephrology in Internet). http:/www.uninet.edu/cin2003/conf/aboud/aboud.html
  13. Wiwanitkit V. Acute renal failure in the fatal cases of dengue hemorrhagic fever, a summary in Thai death cases. Ren Fail. 2005;27:647
  14. Nair VR, Unnikrishnan D, Satish B, Sahadulla MI. Acute renal failure in dengue fever in the absence of bleeding manifestations or shock. Infec Dis Clin Pract. 2005;13:142–143
  15. Wiersinga WJ, Scheepstra CG, Kasanardjo JS, de Vries PJ, Zaaijer H, Geerlings SE. Dengue fever-induced hemolytic uremic syndrome. Clin Infect Dis. 2006;43:800–801
  16. Garcia JH, Rocha TD, Viana CF, et al. Dengue shock syndrome in a liver transplant recipient. Transplantation. 2006;82:850–851
  17. Karakus A, Banga N, Voorn GP, Meinders AJ. Dengue shock syndrome and rhabdomyolysis. Neth J Med. 2007;65:78–81
  18. Khan NA, Azhar EI, El-Fiky S, Madani HH, Abduljadial MA, Ashshi AM, et al. Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia. Acta Trop. 2008;105:39–44
  19. Lima EQ, Gorayeb FS, Zanon JR, Nogueira ML, Ramalho HJ, Burdmann EA. Dengue haemorrhagic fever-induced acute kidney injury without hypotension, haemolysis or rhabdomyolysis. Nephrol Dial Transplant. 2007;22:3322–3326
  20. Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol. 2005;16:3669–3679
  21. Ardalan MR, Tubs RS, Chinikar S, Shoja MM. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant. 2006;21:2304–2307
  22. AlHazmi M, Ayoola EA, Abdurahman M, Banzal S, Ashraf J, El-Busra A, et al. Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis. 2003;36:245–252
  23. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42
  24. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563–1566
  25. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J. 2004;80:588–601
  26. Halstead S. Dengue. Lancet. 2007;370:1644–1652
  27. da Fonseca BA, Fonseca SN. Dengue virus infections. Curr Opin Pediatr. 2002;14:67–71
  28. Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189:1411–1418
  29. Horvath R, McBride WJH, Hanna JN. Clinical features of hospitalized patients during Dengue-3 epidemic in Far North Queensland, 1997-1999. Dengue Bull. 1999;23:20–24
  30. Boonpucknavig S, Vuttiviroj O, Boonpucknavig V. Infection of young adult mice with dengue virus type 2. Trans R Soc Trop Med Hyg. 1981;75:647–653
  31. Barreto DF, Takiya CM, Paes MV, et al. Histopathological aspects of Dengue-2 virus infected mice tissues and complementary virus isolation. J Submicrosc Cytol Pathol. 2004;36:121–130
  32. Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS. Autoimmune pathogenesis in dengue virus infection. Viral Immunol. 2006;19:127–132
  33. Bray M. Pathogenesis of viral hemorrhagic fever. Curr Opin Immunol. 2005;17:399–403
  34. Lin CF, Ley HF, Shiau AL, Liu CC, Liu HS, Yeh TM, et al. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol. 2003;69:82–90
  35. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193:1078–1088
  36. Azevedo LS, Carvalho DBM, Matuck T, Alvarenga MF, Morgado L, Magalhaes I, et al. Dengue in renal transplant patients: a retrospective analysis. Transplantation. 2007;84:792–794
  37. Figueiredo LT. The Brazilian flaviviruses. Microbes Infect. 2000;2:1643–1649
  38. Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1:11–20
  39. Vasconcelos PF. Yellow fever. Rev Soc Bras Med Trop. 2003;36:275–293
  40. Benchimol JL. Febre amarela: a doença e a vacina, uma história inacabada. 2001;ed. FIOCRUZ
  41. Filippis AM, Nogueira RM, Jabor AV, Schatzmayr HG, Oliveira JC, Dinis SC, et al. Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil. Vaccine. 2004;22:1073–1078
  42. Tesh RB. Viral hemorrhagic fevers of South America. Biomedica. 2002;22:287–295
  43. Van der Stuyft P, Gianella A, Pirard M, Cespedes J, Lora J, Peredo C, et al. Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet. 1999;353:1558–1562
  44. Vasconcelos PF, Costa ZG, Travassos Da Rosa ES, Luna E, Rodrigues SG, Barros VL, et al. Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread. J Med Virol. 2001;65:598–604
  45. Massad E, Burattini MN, Coutinho FA, Lopez LF. Dengue and the risk of urban yellow fever reintroduction in Sao Paulo State, Brazil. Rev Saude Publica. 2003;37:477–484
  46. Figueiredo LT. Viral hemorrhagic fevers in Brazil. Rev Soc Bras Med Trop. 2006;39:203–210
  47. de Morais Bronzoni RV, Baleotti FG, Ribeiro Nogueira RM, Nunes M, Moraes Figueiredo LT. Duplex reverse transcription-PCR followed by nested PCR assays for detection and identification of Brazilian alphaviruses and flaviviruses. J Clin Microbiol. 2005;43:696–702
  48. Monath TP, Barrett AD. Pathogenesis and pathophysiology of yellow fever. Adv Virus Res. 2003;60:343–395
  49. Quaresma JA, Barros VL, Pagliari C, Fernandes ER, Andrade HF, Vasconcelos PF, et al. Hepatocyte lesions and cellular immune response in yellow fever infection. Trans R Soc Trop Med Hyg. 2007;101:161–168
  50. Serie C, Lindrec A, Poirier A, Andral L, Neri P. Studies on yellow fever in Ethiopia (I. Introduction—clinical symptoms of yellow fever). Bull World Health Organ. 1968;38:835–841
  51. Monath TP, Brinker KR, Chandler FW, Kemp GE, Cropp CB. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am J Trop Med Hyg. 1981;30:431–433
  52. De Brito T, Siqueira SA, Santos RT, Nassar ES, Coimbra TL, Alves VA. Human fatal yellow fever (Immunohistochemical detection of viral antigens in the liver, kidney and heart). Pathol Res Pract. 1992;188:177–181
  53. Vasconcelos PFC, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VLRS, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet. 2001;358:91–97
  54. Gershy-Damet GM. Ultrastructural changes caused by yellow fever virus at the level of the kidneys in newborn mice. Arch Inst Pasteur Tunis. 1984;61:97–106
  55. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. ed 2. Geneva, Switzerland: World Health Organization; 1997;

 Emerson Q. Lima was supported in part by a grant from Fundação de Amparo à Pesquisa do Estado de Säo Paulo (FAPESP), Brazil; and Mauricio L. Nogueira was supported by FAPESP and Conselho Nacional de Desenvolvimento Científico e Tecnológico grants.

PII: S0270-9295(08)00087-9

doi: 10.1016/j.semnephrol.2008.04.009

Seminars in Nephrology
Volume 28, Issue 4 , Pages 409-415 , July 2008

Article Tools